Announcement no. 12/2007


Summary: Exiqon generated revenue of DKK 21 million, of which product sales
amounted to DKK 15 million. The development of diagnostic products proceeded
according to plan. Operating expenses amounted to DKK 51 million, and the loss
for the period totalled DKK 30 million. Exiqon retains its full-year financial
forecast. 

Attachments

announcement no 12-2007.pdf